Business Description
Editas Medicine Inc
NAICS : 325412
SIC : 2834
ISIN : US28106W1036
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.21 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | -0.19 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.75 | |||||
Beneish M-Score | -1.48 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.8 | |||||
3-Year EBITDA Growth Rate | 1.3 | |||||
3-Year EPS without NRI Growth Rate | -0.7 | |||||
3-Year FCF Growth Rate | 17.3 | |||||
3-Year Book Growth Rate | -12.1 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.19 | |||||
9-Day RSI | 44.01 | |||||
14-Day RSI | 42.75 | |||||
6-1 Month Momentum % | -51.38 | |||||
12-1 Month Momentum % | -56.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.85 | |||||
Quick Ratio | 3.85 | |||||
Cash Ratio | 3.76 | |||||
Days Sales Outstanding | 16.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.3 | |||||
Shareholder Yield % | -0.42 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -317.78 | |||||
Net Margin % | -288.59 | |||||
FCF Margin % | -258.02 | |||||
ROE % | -59.13 | |||||
ROA % | -40.8 | |||||
ROIC % | -133.25 | |||||
ROC (Joel Greenblatt) % | -457.77 | |||||
ROCE % | -51.86 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.86 | |||||
PB Ratio | 1.12 | |||||
Price-to-Tangible-Book | 1.12 | |||||
EV-to-EBIT | -0.1 | |||||
EV-to-Forward-EBIT | -2.05 | |||||
EV-to-EBITDA | -0.1 | |||||
EV-to-Forward-EBITDA | -2.08 | |||||
EV-to-Revenue | 0.31 | |||||
EV-to-Forward-Revenue | 0.92 | |||||
EV-to-FCF | -0.12 | |||||
Price-to-Net-Current-Asset-Value | 1.95 | |||||
Price-to-Net-Cash | 2.07 | |||||
Earnings Yield (Greenblatt) % | -1000 | |||||
FCF Yield % | -65.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Editas Medicine Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 61.586 | ||
EPS (TTM) (€) | -2.187 | ||
Beta | 1.27 | ||
Volatility % | 111.28 | ||
14-Day RSI | 42.75 | ||
14-Day ATR (€) | 0.108078 | ||
20-Day SMA (€) | 3.14485 | ||
12-1 Month Momentum % | -56.05 | ||
52-Week Range (€) | 2.87 - 10.4 | ||
Shares Outstanding (Mil) | 82.48 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Editas Medicine Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Editas Medicine Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Editas Medicine Inc Frequently Asked Questions
What is Editas Medicine Inc(FRA:8EM)'s stock price today?
When is next earnings date of Editas Medicine Inc(FRA:8EM)?
Does Editas Medicine Inc(FRA:8EM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |